Large-scale testing (Phase 3)Study completedNCT05526716
What this trial is testing
Evaluate the Safety, Tolerability, and Immunogenicity of V116 When Administered Concomitantly With Influenza Vaccine in Adults 50 Years of Age or Older (V116-005, STRIDE-5)
Who this might be right for
Pneumonia, Pneumococcal
Merck Sharp & Dohme LLC 1,080